Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients

News   Aug 02, 2013

 
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
 
 
 
 

RELATED ARTICLES

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

Enterome and Nestlé Health Sciences Launch New Diagnostics Company

News

Enterome and Nestlé Health Sciences join to create Microbiome Diagnostics Partners, a company that will enable the development and diagnostics for multiple diseases including inflammatory bowel diseases (IBD) and liver diseases.

READ MORE

Optofluidic Device Detects Tumour Cells in Blood

News

A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE